ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1969

Harmonising Consensus and Reliability Studies in Musculoskeletal Ultrasound

Peter Mandl1, Stine Carstensen2, Lene Terslev3, Carlos Pineda4, Helen Keen5 and Maria-Antonietta D'Agostino6, and OMERACT Ultrasound Working Group, 1Department of Rheumatology, Medical University of Vienna, vienna, Austria, 2Copenhagen Center for Arthritis Research and Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 3Rigshospitalet-Glostrup & COPECARE, Glostrup, Denmark, 4Instituto Nacional de Rehabilitacion, Mexico City, Mexico, 5University of Western Australia, Daglish, Western Australia, Australia, 6Department of Rheumatology, Universita Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, Rome, Italy

Meeting: ACR Convergence 2024

Keywords: Imaging, Psychometrics, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Over the last 20 years musculoskeletal ultrasound (MSUS) was established as a disease outcome measurement instrument. MSUS target domains, including consensual theoretical definitions of pathological processes, operational definitions of elementary lesions, acquisition standards and scoring systems developed as part of OMERACT methodology have been validated via a step-wise process consisting of Delphi surveys to produce theoretical and operational definitions, and intra- and interobserver reliability exercises based either on still images or videos, or on live acquisition using patients or healthy subjects to test such theoretical agreement. Our goal was to evaluate factors influencing Delphi- and reliability exercises in MSUS for developing recommendations to standardise consensus and validation studies aiming at producing new scoring systems.

Methods: A systematic search of the Central, Embase, and Medline databases was performed by two independent reviewers in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Original articles published in English up to May 2024, reporting on Delphi consensus studies and intra- and interobserver reliability exercises performed on adult patients or healthy subjects according to the OMERACT Ultrasound Working Group (USWG) methodology were included. Attributes of the consensus studies and reliability exercises were extracted from the included studies using a predefined sheet.

Results: Out of 2744 articles, 25 were included in the final review. Of these, 15 reported on Delphi studies, while 25 reported on 33 reliability exercises (16 image-based and 17 patient-based). The majority of the Delphi studies included the target domains elementary lesions (87%) and scoring systems (73%) (Table 1). 86% consisted of up to 3 rounds, and 86% utilised ≥75% as a cut-off for reaching agreement among participants. The no. of participants ranged from 13 to 49, with response rates between 68-100%. With respect to reliability exercises, the no. of images used ranged from 23 to 152, the no. of patients from 6 to 13 and the no. of expert participants from 12-35 (image-based) and 9-19 (patient-based) (Table 2). All but one exercise featured two rounds, and all of them assessed both intra- and interobserver reliability. Exercises used various forms of kappa statistics, while a single exercise utilised an intraclass correlation coefficient to measure reliability. All but a single (97%) of reliability studies evaluated either elementary lesions and/or scoring systems. While 59% of patient-based reliability exercises featured a pre-training exercise, this was the case only in 6% of image-based exercises.

Conclusion: The included Delphi consensus and reliability exercise studies focused on either elementary lesions or scoring systems. Variation was observed in the no. of included experts, images/patients utilized, and the integration of pre-training exercises. These results represent the first step for producing recommendations to harmonise consensus and reliability studies in MSUS, to aid OMERACT groups and other researchers in developing/validating new definitions/scoring systems for imaging outcome measures.

Supporting image 1

Figure 1. Key attributes of Delphi consensus studies in musculoskeletal ultrasound according to the OMERACT Ultrasound Working Group methodology. AC: acquisition standard, EL: elementary lesion; GD: global definition; NA: not available; SS: scoring system

Supporting image 2

Figure 2. Key attributes of intra-/interobserver reliability exercises in musculoskeletal ultrasound according to the OMERACT Ultrasound Working Group methodology. EL: elementary lesion; GD: global definition; NA: not available; SS: scoring system


Disclosures: P. Mandl: AbbVie/Abbott, 5, Alphasigma, 5, Janssen, 6, Novartis, 2, 6, UCB, 5; S. Carstensen: None; L. Terslev: Eli Lilly, 6, Janssen, 1, 6, Novartis, 6, Pfizer, 6, Speakers feeJanssen, Novartis, Pfizer, UCB and GE healthcare, 6, UCB, 1; C. Pineda: None; H. Keen: AbbVie/Abbott, 12, investigator for clinical trials, Australian Rheumatology Association, 4, Biogen, 12, investigator for clinical trials, Emerald, 12, investigator for clinical trials, eTherapeutic Guidelines Australia, 6, Novartis, 12, investigator for clinical trials, Roche, 6, 12, investigator for clinical trials, Sanofi, 12, investigator for clinical trials, Sun, 12, investigator for clinical trials, Syneos, 12, investigator for clinical trials; M. D'Agostino: AbbVie/Abbott, 6, Amgen, 6, AstraZeneca, 6, Boehringer-Ingelheim, 6, Bristol-Myers Squibb(BMS), 6, Eli Lilly, 6, Janssen, 6, Novartis, 6, Pfizer, 6, UCB, 6.

To cite this abstract in AMA style:

Mandl P, Carstensen S, Terslev L, Pineda C, Keen H, D'Agostino M. Harmonising Consensus and Reliability Studies in Musculoskeletal Ultrasound [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/harmonising-consensus-and-reliability-studies-in-musculoskeletal-ultrasound/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/harmonising-consensus-and-reliability-studies-in-musculoskeletal-ultrasound/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology